US2023338657A1PendingUtilityA1
Drug administration controller
Est. expiryJan 17, 2026(expired)· nominal 20-yr term from priority
Inventors:Massi Joe E. Kiani
A61M 5/1723A61M 16/0057A61M 16/12A61M 5/142A61M 2230/30A61M 2230/50A61M 2202/0208A61M 2202/0241A61M 2202/0233A61M 2205/502A61M 2230/42A61M 2230/432A61M 2205/18A61M 2230/204A61M 2230/005A61M 2230/10A61M 2230/207A61M 2205/3375A61M 2205/3592A61M 2230/205A61M 2230/04A61M 2205/3313A61M 2205/3561
82
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A drug administration controller has a sensor that generates a sensor signal to a physiological measurement device, which measures a physiological parameter in response. A control output responsive to the physiological parameter or a metric derived from the physiological parameter causes a drug administration device to affect a treatment of a person, such as by initiating, pausing, halting or adjusting a dosage of drugs administered to the person.
Claims
exact text as granted — not AI-modified1 . (canceled)
2 . A drug administration method comprising:
measuring a physiological parameter in response to a sensor attached to a patient; deriving a metric corresponding to the physiological parameter; and controlling a drug administration device based upon the metric, wherein the physiological parameter is at least one of: P1, RR, HbMet, or HbCO.
3 . The drug administration method according to claim 2 , wherein the metric is a least one of: a parameter limit, a parameter trend, a parameter pattern, or a parameter variability.
4 . The drug administration method according to claim 3 , wherein controlling comprises:
enabling the drug administration device when P1 is trending downward as a marker of pain stimulus.
5 . The drug administration method according to claim 4 , wherein controlling further comprises:
pausing the drug administration device when P1 is not trending downward.
6 . The drug administration method according to claim 3 , wherein controlling comprises:
pausing the drug administration device when HbMet is trending upward.
7 . The drug administration method according to claim 3 , wherein controlling comprises:
pausing the drug administration device when HbMet is above HbMet limit.
8 . The drug administration method according to claim 3 , wherein controlling comprises:
pausing the drug administration device when RR is trending downward.
9 . The drug administration method according to claim 3 , wherein controlling comprises:
pausing the drug administration device when RR is less than a RR limit.
10 . A drug administration method comprising:
measuring a physiological parameter in response to a sensor attached to a patient; deriving a metric corresponding to the physiological parameter; and controlling a drug administration device bases upon the metric, wherein the metric is at least one of: a parameter trend, a parameter pattern, or a parameter variability.
11 . The drug administration method according to claim 10 , wherein the physiological parameter is at least one of: SpO 2 , PR, P1, RR, HbMet, or HbCo.
12 . The drug administration method according to claim 11 , wherein controlling comprises:
enabling the drug administration device when P1 is trending downward.
13 . The drug administration method according to claim 11 , wherein controlling comprises:
pausing the drug administration device when HbMet is trending upward.
14 . The drug administration method according to claim 11 , wherein controlling comprises:
pausing the drug administration device when RR is trending downward.
15 . The drug administration method according to claim 11 , wherein controlling comprises:
pausing the drug administration device when a number of cyclical desaturations over a given timeframe is greater than a predetermined threshold.
16 . A drug administration controller comprising:
at least one sensor that generates at least one sensor signal in response to a physiological state of a living being; at least one physiological measurement device that generates measurements of at least one physiological parameter in response to the at least one sensor signal; one or more processors that generate a control output in response to the measurements of the at least one physiological parameter; and a drug administration device responsive to one or more control outputs so as to affect a treatment of the living being including at least one of: initiating, pausing, halting, or adjusting a dosage of administered drugs.
17 . The drug administration controller according to claim 16 , wherein the drug administration device is one of: a drug infusion device, or a medical gas inhalation device.
18 . The drug administration controller according to claim 17 , wherein the at least one sensor comprises:
an optical sensor attached to a tissue site so as to measure at least one blood parameter; and a sound sensor attached proximate to a neck site so as to measure respiration rate.
19 . The drug administration controller according to claim 18 , wherein the at least one blood parameter comprises at least one of: HbMet or HbCO.
20 . The drug administration controller according to claim 19 further comprising:
at least one metric derived from the at least one physiological parameter; and
at least one rule relating the at least one metric to the control output.Join the waitlist — get patent alerts
Track US2023338657A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.